Tumour necrosis factor‐alpha antagonists for treatment of paediatric Crohn’s disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Tumour Necrosis Factor‐alpha Antagonists for Treatment of Paediatric Crohn’s Disease." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/438160/all/Tumour_necrosis_factor‐alpha_antagonists_for_treatment_of_paediatric_Crohn_s_disease.
Tumour necrosis factor‐alpha antagonists for treatment of paediatric Crohn’s disease. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438160/all/Tumour_necrosis_factor‐alpha_antagonists_for_treatment_of_paediatric_Crohn_s_disease. Accessed March 26, 2025.
Tumour necrosis factor‐alpha antagonists for treatment of paediatric Crohn’s disease. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438160/all/Tumour_necrosis_factor‐alpha_antagonists_for_treatment_of_paediatric_Crohn_s_disease
Tumour Necrosis Factor‐alpha Antagonists for Treatment of Paediatric Crohn’s Disease [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 March 26]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/438160/all/Tumour_necrosis_factor‐alpha_antagonists_for_treatment_of_paediatric_Crohn_s_disease.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Tumour necrosis factor‐alpha antagonists for treatment of paediatric Crohn’s disease
ID - 438160
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/438160/all/Tumour_necrosis_factor‐alpha_antagonists_for_treatment_of_paediatric_Crohn_s_disease
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -